These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17963633

  • 1. [The effect on electrocardiographic and cardiac autonomic function after percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy].
    Xing YB, Guo HY, Wang P, You BQ, Chen JZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Aug; 35(8):731-4. PubMed ID: 17963633
    [Abstract] [Full Text] [Related]

  • 2. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H, Wang P, Xing Y, Peng F, Jiang J, Yang B, You B, Qiu Y, Lee JD.
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T, Lieder F, Bartelsmeier M, Leuner C, Borchert B, Meyer zu Vilsendorf D, Strunk-Mueller C, Reinhardt J, Feuchtl A, Stellbrink C, Kuhn H.
    J Am Coll Cardiol; 2007 Jun 19; 49(24):2356-63. PubMed ID: 17572252
    [Abstract] [Full Text] [Related]

  • 5. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Kazmierczak J, Kornacewicz-Jach Z, Kisly M, Gil R, Wojtarowicz A.
    Heart; 1998 Sep 19; 80(3):257-62. PubMed ID: 9875085
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W, Li Z, Zhang M, Yuan L, Guan R, Hou A, Jin Y, Deng Z.
    Chin Med J (Engl); 2002 Sep 19; 115(9):1283-6. PubMed ID: 12411095
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prognostic value of acute heart block after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy].
    Hou AJ, Duan N, Yang L, Li HJ, Li ZQ, Yuan L, Guan RM, Liu Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb 19; 37(2):149-51. PubMed ID: 19719994
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MR imaging evaluation of regional, remote, and global effects of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Amano Y, Takayama M, Kumita S, Kumazaki T.
    J Comput Assist Tomogr; 2007 Feb 19; 31(4):600-4. PubMed ID: 17882040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation.
    van der Lee C, Scholzel B, ten Berg JM, Geleijnse ML, Idzerda HH, van Domburg RT, Vletter WB, Serruys PW, ten Cate FJ.
    Am J Cardiol; 2008 May 01; 101(9):1315-20. PubMed ID: 18435964
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.